BUSINESS● LOWAug 5 · Aug 5, 2026, 12:20 AM
Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027
Seeking Alpha Tech
Bio-Rad forecasts its 2026 currency-neutral revenue growth and targets specific net cost savings by the end of 2027. This outlines the company's financial projections and efficiency goals.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowMines, telecoms, factories… Will African industrialists succeed in doing without diesel?Jeune AfriqueBUSINESS8m agoIridium CommunicationsEPS of $0.98, revenue of $245.7M misses by $2.84MSeeking Alpha Tech